{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:26:49Z","timestamp":1781108809681,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T00:00:00Z","timestamp":1533513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00115-018-0590-5","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T10:20:13Z","timestamp":1533550813000},"page":"167-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Charakteristika und Dynamik der station\u00e4ren Behandlung von Parkinson-Patienten in Deutschland","Characteristics and dynamics of inpatient treatment of patients with Parkinson\u2019s disease in Germany"],"prefix":"10.1007","volume":"90","author":[{"given":"L.","family":"T\u00f6nges","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bartig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Muhlack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Krogias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,6]]},"reference":[{"key":"590_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","volume":"16","author":"AL Boxer","year":"2017","unstructured":"Boxer AL, Yu JT, Golbe LI et\u00a0al (2017) Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches. Lancet Neurol 16:552\u2013563","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"590_CR2","first-page":"S36","volume":"84","author":"C Buhmann","year":"2016","unstructured":"Buhmann C, Bass H, Hahne M et al (2016) Das idiopathische Parkinson-Syndrom an der Grenze von ambulanter zu station\u00e4rer Versorgung. Fortschr Neurol Psychiatr 84(Suppl 1):S36\u2013S40","journal-title":"Fortschr Neurol Psychiatr"},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson pandemic\u2014a call to action. Jama Neurol 75:9\u201310","journal-title":"Jama Neurol"},{"key":"590_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000477165","volume":"78","author":"D Enders","year":"2017","unstructured":"Enders D, Balzer-Geldsetzer M, Riedel O et al (2017) Prevalence, duration and severity of Parkinson\u2019s disease in Germany: a combined meta-analysis from literature data and outpatient samples. Eur Neurol 78:128\u2013136","journal-title":"Eur Neurol"},{"key":"590_CR5","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1056\/NEJMoa033447","volume":"351","author":"S Fahn","year":"2004","unstructured":"Fahn S, Oakes D, Shoulson I et\u00a0al (2004) Levodopa and the progression of Parkinson\u2019s disease. N\u00a0Engl J Med 351:2498\u20132508","journal-title":"N Engl J Med"},{"key":"590_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1056\/NEJMra1311488","volume":"372","author":"A Fanciulli","year":"2015","unstructured":"Fanciulli A, Wenning GK (2015) Multiple-system atrophy. N\u00a0Engl J Med 372:249\u2013263","journal-title":"N Engl J Med"},{"key":"590_CR7","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman S, Wenning GK, Low PA et\u00a0al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670\u2013676","journal-title":"Neurology"},{"key":"590_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","volume":"16","author":"Group GBDNDC","year":"2017","unstructured":"Group GBDNDC (2017) Global, regional, and national burden of neurological disorders during 1990\u20132015: a\u00a0systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurol 16:877\u2013897","journal-title":"Lancet Neurol"},{"key":"590_CR9","volume-title":"Versorgungs-Report 2012: Schwerpunkt: Gesundheit im Alter","author":"C G\u00fcnster","year":"2012","unstructured":"G\u00fcnster C, Klose J, Schmacke N (2012) Versorgungs-Report 2012: Schwerpunkt: Gesundheit im Alter. Schattauer, Stuttgart"},{"key":"590_CR10","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","volume":"21","author":"A Gustavsson","year":"2011","unstructured":"Gustavsson A, Svensson M, Jacobi F et\u00a0al (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:718\u2013779","journal-title":"Eur Neuropsychopharmacol"},{"key":"590_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00500","author":"S Heinzel","year":"2018","unstructured":"Heinzel S, Berg D, Binder S et\u00a0al (2018) Do we need to rethink the epidemiology and healthcare utilization of Parkinson\u2019s disease in Germany? Front Neurol. \n                    https:\/\/doi.org\/10.3389\/fneur.2018.00500","journal-title":"Front Neurol"},{"key":"590_CR12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.parkreldis.2012.04.026","volume":"18","author":"DE Hobson","year":"2012","unstructured":"Hobson DE, Lix LM, Azimaee M et al (2012) Healthcare utilization in patients with Parkinson\u2019s disease: a\u00a0population-based analysis. Parkinsonism Relat Disord 18:930\u2013935","journal-title":"Parkinsonism Relat Disord"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU Hoglinger","year":"2017","unstructured":"Hoglinger GU, Respondek G, Stamelou M et\u00a0al (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853\u2013864","journal-title":"Mov Disord"},{"key":"590_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrneurol.2015.61","volume":"11","author":"AD Korczyn","year":"2015","unstructured":"Korczyn AD (2015) Vascular parkinsonism\u2014characteristics, pathogenesis and treatment. Nat Rev Neurol 11:319\u2013326","journal-title":"Nat Rev Neurol"},{"key":"590_CR15","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00702-017-1707-x","volume":"124","author":"R Kruger","year":"2017","unstructured":"Kruger R, Klucken J, Weiss D et\u00a0al (2017) Classification of advanced stages of Parkinson\u2019s disease: translation into stratified treatments. J\u00a0Neural Transm (Vienna) 124:1015\u20131027","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"590_CR16","first-page":"61","volume":"113","author":"J Levin","year":"2016","unstructured":"Levin J, Kurz A, Arzberger T et\u00a0al (2016) The differential diagnosis and treatment of atypical Parkinsonism. Dtsch Arztebl Int 113:61\u201369","journal-title":"Dtsch Arztebl Int"},{"key":"590_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2016.05.013","volume":"28","author":"AD Macleod","year":"2016","unstructured":"Macleod AD, Goddard H, Counsell CE (2016) Co-morbidity burden in Parkinson\u2019s disease: comparison with controls and its influence on prognosis. Parkinsonism Relat Disord 28:124\u2013129","journal-title":"Parkinsonism Relat Disord"},{"key":"590_CR18","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et\u00a0al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"590_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1002\/mds.26362","volume":"30","author":"O Rascol","year":"2015","unstructured":"Rascol O, Perez-Lloret S, Ferreira JJ (2015) New treatments for levodopa-induced motor complications. Mov Disord 30:1451\u20131460","journal-title":"Mov Disord"},{"key":"590_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/mds.26839","volume":"32","author":"R Savica","year":"2017","unstructured":"Savica R, Grossardt BR, Bower JH et al (2017) Incidence and time trends of drug-induced parkinsonism: a 30-year population-based study. Mov Disord 32:227\u2013234","journal-title":"Mov Disord"},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S1474-4422(17)30167-9","volume":"16","author":"RB Schneider","year":"2017","unstructured":"Schneider RB, Biglan KM (2017) The promise of telemedicine for chronic neurological disorders: the example of Parkinson\u2019s disease. Lancet Neurol 16:541\u2013551","journal-title":"Lancet Neurol"},{"key":"590_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1055\/s-0043-103275","volume":"85","author":"L Tonges","year":"2017","unstructured":"Tonges L, Ehret R, Lorrain M et\u00a0al (2017) Epidemiologie der Parkinsonerkrankung und aktuelle ambulante Versorgungskonzepte in Deutschland. Fortschr Neurol Psychiatr 85:329\u2013335","journal-title":"Fortschr Neurol Psychiatr"},{"key":"590_CR23","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archneur.1995.00540340109020","volume":"52","author":"C Trenkwalder","year":"1995","unstructured":"Trenkwalder C, Schwarz J, Gebhard J et al (1995) Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson\u2019s disease and related disorders assessed by a\u00a0door-to-door survey of inhabitants older than 65 years. Arch Neurol 52:1017\u20131022","journal-title":"Arch Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0590-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0590-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T23:04:29Z","timestamp":1565046269000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0590-5"}},"subtitle":["Analyse von 1,5\u00a0Mio. Patientenf\u00e4llen aus den Jahren 2010 bis 2015","Analysis of 1.5 million patient cases from 2010 to 2015"],"short-title":[],"issued":{"date-parts":[[2018,8,6]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0590-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,6]]},"assertion":[{"value":"6 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"L.\u00a0T\u00f6nges, D.\u00a0Bartig, S.\u00a0Muhlack, W.\u00a0Jost, R.\u00a0Gold und C.\u00a0Krogias geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}